TeraRecon, one of the top industry leaders in state-of-the-art visualization and artificial intelligence (AI) for medical imaging, has launched its advanced Eureka Clinical AI system. The Eureka Clinical AI system is engineered to assist the communication infrastructure and facilitate participation for the whole care team. It acts as an end-to-end clinical application incorporating several AI algorithms and workflows. The new system backs dual desktop and mobile viewers for cross-specialty partnership and patient-specific sharing of AI outcomes to speed up access to mission-critical images and perceptions in a timely manner. The AI system is exclusive in assisting third-party, customer-developed, and TeraRecon-created AI algorithms in a single unified workflow with comprehensible model-management features.

VIDA Diagnostics, Inc. ("VIDA"), the leader in AI-powered lung imaging analysis, announced a distribution agreement with TeraRecon, Inc., a leader in advanced visualization, artificial intelligence, image viewing, and post-processing. With this agreement, VIDA's LungPrint analysis will be available through TeraRecon's AI Interoperability platform, EnvoyAI, expanding the reach of VIDA's leading AI-powered pulmonary care solutions and creating an integrated physician experience. LungPrint Discovery offers fully automatic radiological metrics and unique, time-saving airway visualizations. By precisely quantifying lung characteristics in a chest CT scan, LungPrint helps providers detect COPD and other interstitial lung diseases earlier, often when debilitating symptoms have yet to occur. Early detection of chronic lung disease is reported to elongate life expectancies and reduce overall healthcare costs (Larsson, et.

TeraRecon, Ambra Health and EnvoyAI announced a new collaboration March 6 to create an artificial intelligence (AI)-enhanced image exchange workflow for healthcare providers, according to a recent press release. "Through our partnerships with Ambra Health and TeraRecon, our technology can reach remote, single physician practices while also meeting the most demanding clinical needs of the largest integrated health systems," said Jake Taylor, CTO of EnvoyAI. The new partnership will allow providers to implement AI through an Ambra image exchange workflow while having full access to an AI algorithm portfolio available on the EnvoyAI Exchange, ultimately leveraging healthcare provdiers' current PACS and the full range of TeraRecon viewers, according to the press release. "This interoperability partnership gives healthcare providers in the Ambra network access to bleeding edge AI technology for advanced image visualization, providing the very latest technological innovations to continually improve patient outcomes and care," said Andrew Duckworth, vice president of business development for Ambra Health, in a prepared statement. The new AI workflow will be on display until Thursday, March 8. at HIMSS18 annual meeting in Las Vegas.